Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.91 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.88 |
| ▸ | MAPT | P10636 | 4/20 | 0.88 |
| ▸ | LMNA | P02545 | 4/20 | 0.88 |
| ▸ | MEN1 | O00255 | 4/20 | 0.88 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.88 |
| ▸ | GMNN | O75496 | 3/20 | 0.88 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.88 |
| ▸ | TP53 | P04637 | 3/20 | 0.88 |
| ▸ | TSHR | P16473 | 3/20 | 0.88 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.88 |
| ▸ | BLM | P54132 | 2/20 | 0.88 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.88 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.88 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.88 |
| ▸ | GLA | P06280 | 1/20 | 0.86 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.86 |
| ▸ | SLC25A20 | O43772 | 3/20 | 0.67 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.67 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8617150 | 0.98 | MAPK1 (0.89) | CYP1A2MAPK1MAPTLMNAMEN1 | |
| Hydrochloric Acid SCHEMBL28699980 | 0.98 | CYP1A2 (0.88) | CYP1A2MAPK1MAPTLMNAMEN1 | |
| Hydrochloric Acid SCHEMBL8617144 | 0.98 | MAPK1 (0.89) | CYP1A2MAPK1MAPTLMNAMEN1 | |
| Hydrochloric Acid SCHEMBL8617151 | 0.98 | MAPK1 (0.89) | CYP1A2MAPK1MAPTLMNAMEN1 | |
| SCHEMBL12648561 | 0.95 | CYP1A2 (1.00) | CYP1A2MAPK1MAPTLMNAMEN1 | |
| SCHEMBL21594810 | 0.95 | CYP1A2 (1.00) | CYP1A2MAPK1MAPTLMNAMEN1 | |
| SCHEMBL25375657 | 0.94 | MAPK1 (1.00) | CYP1A2MAPK1MAPTLMNAMEN1 | |
| SCHEMBL21569424 | 0.94 | MAPK1 (1.00) | CYP1A2MAPK1MAPTLMNAMEN1 | |
| SCHEMBL22392377 | 0.94 | MAPK1 (1.00) | CYP1A2MAPK1MAPTLMNAMEN1 | |
| SCHEMBL21114352 | 0.94 | MAPK1 (1.00) | CYP1A2MAPK1MAPTLMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116994762-B | Construction method and application of M Index model for MMDS auxiliary diagnosis | 中山大学附属第六医院 | 2023-12-22 | — | — | CN | claimed |
| US-11808774-B2 | Metabolic biomarkers for memory loss | GEORGETOWN UNIVERSITY (US) | 2023-11-07 | — | — | US | claimed |
| CN-116994762-A | Construction method and application of M Index model for MMDS auxiliary diagnosis | 中山大学附属第六医院 | 2023-11-03 | — | — | CN | claimed |
| CN-101616665-B | Composition useful for the treatment of type 2 diabetes | SIGMA TAU IND FARMACEUTI IT | 2013-03-27 | — | — | CN | claimed |
| US-20240358676-A1 | COMPOSITIONS AND METHODS FOR PAIN RELIEF | CROSS III WILLIAM H (US) | 2024-10-31 | — | — | US | disclosed |
| US-12036206-B2 | Compositions and methods for pain relief | CROSS III WILLIAM H (US) | 2024-07-16 | — | — | US | disclosed |
| CN-117174923-B | Graphite felt for enhancing solid-liquid interface interaction and preparation method thereof | 杭州德海艾科能源科技有限公司 | 2024-02-06 | — | — | CN | disclosed |
| CN-116994762-B | Construction method and application of M Index model for MMDS auxiliary diagnosis | 中山大学附属第六医院 | 2023-12-22 | — | — | CN | disclosed |
| CN-117174923-A | Graphite felt for enhancing solid-liquid interface interaction and preparation method thereof | 杭州德海艾科能源科技有限公司 | 2023-12-05 | — | — | CN | disclosed |
| US-11808774-B2 | Metabolic biomarkers for memory loss | GEORGETOWN UNIVERSITY (US) | 2023-11-07 | — | — | US | disclosed |
| CN-116994762-A | Construction method and application of M Index model for MMDS auxiliary diagnosis | 中山大学附属第六医院 | 2023-11-03 | — | — | CN | disclosed |
| WO-2023145880-A1 | GLUTAMINASE INHIBITOR | 国立大学法人富山大学 | 2023-08-03 | — | — | WO | disclosed |
| US-20180050048-A1 | CONJUGATE COMPOUNDS OF URSODEOXYCHOLIC, BERBERINE OR L-CARNITINE, AND COMPOSITIONS AND METHODS THEREOF | SHENZHEN HIGHTIDE BIOPHARMACEUTICAL, LTD. (CN) | 2018-02-22 | — | — | US | disclosed |
| CN-106537145-A | Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment | 麦特博隆股份有限公司 | 2017-03-22 | — | — | CN | disclosed |
| US-20170037043-A1 | BERBERINE SALTS, URSODEOXYCHOLIC SALTS AND COMBINATIONS, METHODS OF PREPARATION AND APPLICATION THEREOF | SHENZHEN HIGHTIDE BIOPHARMACEUTICAL, LTD. (CN) | 2017-02-09 | — | — | US | disclosed |
| US-8067468-B2 | L-carnitine and alkanoyl L-carnitine phytates and process for preparing the same | SCIAN LABORATORIES, LLC | 2011-11-29 | — | — | US | disclosed |
| US-8067468-B2 | L-carnitine and alkanoyl L-carnitine phytates and process for preparing the same | SCIAN LABORATORIES, LLC | 2011-11-29 | — | — | US | disclosed |
| US-20100317890-A1 | L-carnitine and alkanoyl L-carnitine phytates and process for preparing the same | SCIAN LABORATORIES, LLC (US) | 2010-12-16 | — | — | US | disclosed |
| US-20100317890-A1 | L-carnitine and alkanoyl L-carnitine phytates and process for preparing the same | SCIAN LABORATORIES, LLC (US) | 2010-12-16 | — | — | US | disclosed |
| WO-2010005465-A1 | L-CARNITINE AND ALKANOYL L-CARNITINE PHYTATES AND PROCESS FOR PREPARING THE SAME | SCIAN LABORATORIES, LLC (US) | 2010-01-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170037043-A1 | BERBERINE SALTS, URSODEOXYCHOLIC SALTS AND COMBINATIONS, METHODS OF PREPARATION AND APPLICATION THEREOF | CYP27A1, NR1H4, CYP7A1 | CYP1A2 281/4885MAPK1 1212/4885MAPT 1349/4885 |
| US-12036206-B2 | Compositions and methods for pain relief | CBS, CTH, CPT1B | CYP1A2 2570/4885MAPK1 3994/4885MAPT 563/4885 |
| US-20240358676-A1 | COMPOSITIONS AND METHODS FOR PAIN RELIEF | CBS, CTH, CPT1B | CYP1A2 2570/4885MAPK1 3994/4885MAPT 563/4885 |
| US-20100317890-A1 | L-carnitine and alkanoyl L-carnitine phytates and process for preparing the same | CPT1A, CPT1B, SLC25A20 | CYP1A2 2417/4885MAPK1 2354/4885MAPT 3049/4885 |
| US-20180050048-A1 | CONJUGATE COMPOUNDS OF URSODEOXYCHOLIC, BERBERINE OR L-CARNITINE, AND COMPOSITIONS AND METHODS THEREOF | HMGCR, COASY, CPT1A | CYP1A2 2013/4885MAPK1 2562/4885MAPT 3807/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.